Skip to main content
Premium Trial:

Request an Annual Quote

3EO Health Navigation System

Point-of-care diagnostic company 3EO Health has launched its molecular COVID-19 test, which received Emergency Use Authorization from the US Food and Drug Administration last year. The COVID-19 test uses the firm's 3TR amplification technology, runs on 3EO's portable molecular analyzer, called the Cube, and requires no sample preparation. The company is currently providing its analyzers to US physicians' offices at no cost, it said in a statement.